Day: December 18, 2025

Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate to the company’s Interventional Urology business as well as the global People & Culture function. Executive Vice President of People & Culture, Dorthe Rønnau, has decided to leave Coloplast to pursue the next chapter in her career. She has spent close to three decades in different roles across the Coloplast Group. “Dorthe’s values, integrity and strong leadership skills have benefitted the company across her roles in Global Operations, Atos and People & Culture, and in her role in the ELT,” says Lars Rasmussen, interim CEO of Coloplast. An external search is currently on-going to identify a new leader of the global People & Culture function. Dorthe Rønnau will have her last day at Coloplast at the end of February,...

December 18, 2025 Biodexa Announces Pricing of $10 Million Public Offering Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) (“Biodexa” or the “Company”), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the pricing of a best efforts public offering of an aggregate of (i) 157,000 units (the “ADS Units”), with each unit consisting of (A) one American depositary share (representing 100,000 of the Company’s ordinary shares) (“ADSs”), and (B) two Series L warrants, each to purchase one ADS (the “Series L Warrants”), and (ii) 2,891,781 pre-funded units (the “Pre-Funded Units”), with each Pre-Funded Unit consisting of (A) one pre-funded warrant to purchase one ADS and (ii) two Series L Warrants. The combined public offering price of each...

DALLAS, Dec. 18, 2025 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (the “Company,” or “Applied Digital”), a builder and operator of next-generation digital infrastructure designed for high-performance computing (“HPC”) and artificial intelligence (“AI”) workloads, today announced it has entered into a loan facility with Macquarie Group’s Commodities and Global Market’s business (“Macquarie”) to fund the pre-lease development costs for new data center projects. The facility was entered into on December 18, 2025, by APLD DevCo LLC, a wholly owned subsidiary of Applied Digital, and Macquarie and provides pre-lease development capital to support the early-stage sourcing, planning, development, and construction of new data center campuses and other potential projects. Applied Digital is currently in advanced-stage negotiations...

LAS VEGAS, Dec. 18, 2025 (GLOBE NEWSWIRE) — Starstream Entertainment Inc. (OTCID:SSET) today announced it has signed a non-binding Letter of Intent (LOI) to pursue the proposed acquisition of CityWalk e-Bike Inc., a China-based electric bicycle company. The proposed transaction is subject to customary conditions, including completion of due diligence, negotiation and execution of definitive documentation, and any applicable regulatory, corporate, and shareholder approvals. There can be no assurance that a definitive agreement will be reached or that the proposed transaction will be completed. “We believe this LOI is an important step in evaluating a strategic opportunity that may strengthen Starstream’s operating platform and create long-term shareholder value,” said Mr. Ding Zhao, CEO of Starstream Entertainment Inc. SSET will...

PTOP Intelligence Labs to power EXOS Aerospace’s communications with AI-driven automation and investor outreach tools Takeaways:PTOP Intelligence Labs to integrate proprietary AI stack on EXOS Aerospace’s website New system will automate investor outreach and enhance communication of complex aerospace value propositions EXOS to leverage platform for high-frequency, transparent communication with partners and stakeholdersCAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Peer to Peer Network, Inc. (OTC: PTOP) today announced that its AI division, PTOP Intelligence Labs, has entered into a contract with EXOS Aerospace Systems & Technologies, Inc. to deploy PTOP Intelligence Labs’ proprietary technology stack as part of its Tier-1 BETA AI communications platform.Under the agreement, PTOP Intelligence Labs will deploy...

NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES This news release constitutes a “designated news release” for the purposes of Sienna’s amended and restated prospectus supplement dated November 14, 2025 to its short form base shelf prospectus dated November 29, 2024. MARKHAM, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced today that it has completed its previously announced offering (the “Offering”) of $250 million aggregate principal amount of series F senior unsecured debentures (the “Debentures”). The Offering was led by BMO Capital Markets, TD Securities Inc. and CIBC Capital Markets, as joint lead agents and bookrunners. The Debentures were issued at par, bear interest at a rate of 3.524% per annum and will mature...

STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug Administration (FDA) has agreed will serve as an endpoint to support accelerated approval pathway  Isaralgagene civaparvovec continues to show favorable safety and tolerability profile Sangamo expects to complete Biological License Application (BLA) submission under accelerated approval pathway in second quarter of 2026 RICHMOND, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, has initiated a rolling submission of a BLA to the FDA seeking accelerated approval of isaralgagene civaparvovec, or ST-920, a wholly owned investigational gene therapy for the treatment of adults with Fabry disease. Rolling...